Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 34Glioblastoma 8Glioma 7Meningeal Carcinomatosis 6Epilepsy 5Neuroblastoma 4Neoplasms 4Neoplasm Metastasis 4Pituitary Neoplasms 3Meningioma 3Melanoma 3Lung Neoplasms 3Breast Neoplasms 3Seizures 2Retinoblastoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Paraganglioma 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 1 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Delirium 2Central Nervous System Diseases 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Wilms Tumor 1Stroke 1

Interventions

perampanel 1Anticonvulsants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Drug Resistant Epilepsy × CNS × Clear all
NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Mayo Clinic

Phase 4 Terminated
4 enrolled 9 charts
CNS

Drug Resistant Epilepsy, Epilepsy, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡